|
Basic Characteristics of Mutations
|
|
Mutation Site
|
T846C |
|
Mutation Site Sentence
|
The results also showed the prevalence of 4 hot spots of E7 nucleotide variations leading to N29H, N29S, and 2 silent variations, nucleotide G666A and nucleotide T846C, with 4.2% (6/142), 43% (61/142), 32.4% (46/142), and 43% (61/142), respectively. |
|
Mutation Level
|
Nucleotide level |
|
Mutation Type
|
Synonymous substitution |
|
Gene/Protein/Region
|
E7 |
|
Standardized Encoding Gene
|
E7
|
|
Genotype/Subtype
|
HPV16 |
|
Viral Reference
|
KO_2718
|
|
Functional Impact and Mechanisms
|
|
Disease
|
Uterine Cervicitis
Cervical Intraepithelial Neoplasia
Uterine Cervical Neoplasms
|
|
Immune
|
- |
|
Target Gene
|
-
|
|
Clinical and Epidemiological Correlations
|
|
Clinical Information
|
Y |
|
Treatment
|
- |
|
Location
|
China |
|
Literature Information
|
|
PMID
|
21436703
|
|
Title
|
Genetic diversity of HPV-16 E6, E7, and L1 genes in women with cervical lesions in Liaoning Province, China
|
|
Author
|
Sun Z,Ren G,Cui X,Zhou W,Liu C,Ruan Q
|
|
Journal
|
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
|
|
Journal Info
|
2011 Apr;21(3):551-8
|
|
Abstract
|
INTRODUCTION: High-risk human papillomaviruses (HPVs) play a cardinal role in the etiology of cervical cancer. The most prevalent type, HPV-16, shows intratypic sequence variants that are known to differ in oncogenic potential and geographic distribution. Intratype variations in oncogenic E6/E7 and capsid L1 proteins of HPV-16 are associated with risk of viral persistence and progression. METHODS: This study was designed to analyze sequence variations in E6, E7, and L1 genes of HPV-16 in patients with cervical lesion to identify the most prevalent and novel HPV-16 variants in northern China. RESULTS: Our results showed that HPV-16 variants with respect to E6 and E7 were high prevalence of the Asian lineage: 48.3% and 51.4%, respectively. Sequences of the E6 gene revealed 4 amino acid changes of variants D25E and L83V, with 48.3% (69/143) and 11.2% (16/143), respectively, and variants H78Y and E113D in this study. The results also showed the prevalence of 4 hot spots of E7 nucleotide variations leading to N29H, N29S, and 2 silent variations, nucleotide G666A and nucleotide T846C, with 4.2% (6/142), 43% (61/142), 32.4% (46/142), and 43% (61/142), respectively. The following L1 variations were found in this study: L103F, P104K, P104Y, P104S, D105G, P106S, N108P, F109V, C172S, H228D, and T292A. It was also found that 448S was inserted and 465D was deleted in the L1 amino acid sequences of all the samples. No significant relationship between HPV-16 variants and high-grade lesions was found. CONCLUSIONS: The study provides some new data on the genetic diversity of HPV-16, which may help to understand the oncogenic potential of the virus and design the diagnosis reagents and vaccine of HPV in China. Furthermore, in-depth studies are needed to determine the clinical and biological effects of these variants.
|
|
Sequence Data
|
-
|
|
|